Interim PET in lymphoma: a step towards standardization
- 22 July 2010
- journal article
- editorial material
- Published by Springer Science and Business Media LLC in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 37 (10), 1821-1823
- https://doi.org/10.1007/s00259-010-1546-6
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Improvement of Early 18F-FDG PET Interpretation in Diffuse Large B-Cell Lymphoma: Importance of the Reference BackgroundJournal of Nuclear Medicine, 2010
- Are macrophages the bad guys in Hodgkin lymphoma?Nature Reviews Clinical Oncology, 2010
- Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2010
- Risk-Adapted Dose-Dense Immunochemotherapy Determined by Interim FDG-PET in Advanced-Stage Diffuse Large B-Cell LymphomaJournal of Clinical Oncology, 2010
- Interim positron emission tomography scan in Hodgkin lymphoma: definitions, interpretation rules, and clinical validationLeukemia & Lymphoma, 2009
- Prognostic Value of Interim 18F-FDG PET in Patients with Diffuse Large B-Cell Lymphoma: SUV-Based Assessment at 4 Cycles of ChemotherapyJournal of Nuclear Medicine, 2009
- Report on the First International Workshop on interim-PET scan in lymphomaLeukemia & Lymphoma, 2009
- Stromal Gene Signatures in Large-B-Cell LymphomasThe New England Journal of Medicine, 2008
- Early 18F-FDG PET for Prediction of Prognosis in Patients with Diffuse Large B-Cell Lymphoma: SUV-Based Assessment Versus Visual AnalysisJournal of Nuclear Medicine, 2007
- Early Interim 2-[18F]Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography Is Prognostically Superior to International Prognostic Score in Advanced-Stage Hodgkin's Lymphoma: A Report From a Joint Italian-Danish StudyJournal of Clinical Oncology, 2007